Riverbank Capital Securities logo

Riverbank Capital Securities

North America, New York, United States, New York

Description

Riverbank Capital Securities is a New York-based venture capital firm specialized in early and late stage venture investments.

Investor Profile

Riverbank Capital Securities has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Series C (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Riverbank Capital Securities frequently co-invest with?

NGN Capital
North America, New York, United States, New York
Co-Investments: 1
Two River
North America, New York, United States, New York
Co-Investments: 1
SC
North America, New York, United States, Chappaqua
Co-Investments: 1
Wexford Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1

What are some of recent deals done by Riverbank Capital Securities?

Kite Pharma

Los Angeles, California, United States

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series AMar 9, 2011
Amount Raised: $15,000,000
Tigris Pharmaceuticals

Bonita Springs, Florida, United States

Tigris Pharmaceuticals is a biopharmaceutical company developing therapeutic technologies for cancer and other unmet medical needs.

BiotechnologyHealth CarePharmaceutical
Series CSep 28, 2010
Amount Raised: $6,500,000
Tigris Pharmaceuticals

Bonita Springs, Florida, United States

Tigris Pharmaceuticals is a biopharmaceutical company developing therapeutic technologies for cancer and other unmet medical needs.

BiotechnologyHealth CarePharmaceutical
Series BJan 17, 2007
Amount Raised: $16,000,000

Find More Investors Like Riverbank Capital Securities

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Riverbank Capital Securities | Pipeseed